Diversity-Oriented Synthesis of Novel Heterocyclic & Natural Product-Like Library

新型杂环的多样性导向合成

• 批准号: 7499631
• 负责人: Marvin S Yu
• 金额: $ 42.82万
• 依托单位: FLUOROUS TECHNOLOGIES, INC.
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-21 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7499631
• 关键词: Alkaloids; Biological Factors; Birds; Calculi; Characteristics; Chemistry; Cost Control; Coupled; Data; Development; Equilibrium; Ethers; Ethyl Ether; Future; Goals; Grant; Guidelines; Housing; Legal patent; Libraries; Nitrogen; Procedures; Production; Quality Control; Reaction; Resources; Sampling; Screening procedure; Skeletal system; System; Techniques; Technology; Time; United States National Institutes of Health; Variant; data management; design; diketopiperazine; gypsetin; innovation; instrument; interest; isaindigotone; mappicine; novel; scaffold; silochrome; size; small molecule libraries

DESCRIPTION (provided by applicant): Creative library design coupled with an established technology platform is an ideal approach for making small molecule libraries. Utilizing fluorous techniques, we aim to produce novel heterocyclic and natural product-like pilot-scale libraries in an innovative, efficient, and cost-controlled manner. This proposal has the following features: (1) More than half of the proposed library scaffolds are closely related to natural products such as mappicine, isaindigotone, sclerotigenin, and gypsetin. The remaining scaffolds are related to specific structural motifs of natural products or related to the characteristics of natural products in a more general sense, but have high structural novelty and diversity. Libraries produced by diversity-oriented synthesis have skeletal, substitution, and stereochemical variations. (2) Highly efficient and reliable fluorous tagging and separation techniques are used to produce most of the proposed libraries. The use of a "rapid synthesis system" as an integrated synthetic platform dramatically reduces time for both reaction and separation. Other cost control techniques such as "two birds with one stone"-type fluorous tagging/ cleavage, sharing common building blocks, and recovering/reusing fluorous tags and silica gel will be used to produce libraries. (3) The effort on library design/development versus library production is balanced. The design and development of pilot-scale libraries is built upon successful in-house chemistry. More effort is directed toward library production to generate compounds for submission, thus meeting NIH goals. The specific aims are: (1) Synthesis of mappicine-type natural product libraries; (2) Synthesis of isaindigotone-type natural product libraries; (3) Synthesis of sclerotigenin-type natural product libraries; (4) Synthesis of novel and diverse nitrogen-containing polycyclic libraries; (5) Synthesis of diketopiperazine-containing natural product-like libraries; (6) Synthesis of polycyclic ether and alkaloid-type libraries. Over the course of a three-year grant period, around 30 library scaffolds will be developed from 6 projects, resulting in 800-1,000 compounds being produced and submitted each year. RFA general guidelines for library production and submission including library size, quality control, sample delivery, data management, and patent issues will be closely followed. Data generated under this RFA including library synthesis procedures and compound characterization, and research resources such as synthetic technologies and instruments, will be shared willingly with future collaborators that have an interest in screening and/or studying the compounds produced in this proposal.

描述（由申请人提供）：创新的文库设计与已建立的技术平台相结合，是制备小分子文库的理想方法。 利用氟技术，我们的目标是以创新，高效和成本控制的方式生产新型杂环和天然产物样的中试规模库。 该方案具有以下特点：（1）超过一半的文库支架与天然产物如马匹辛、靛地高酮、菌核苷元和gypsetin密切相关。 其余的支架与天然产物的特定结构基序有关，或在更一般的意义上与天然产物的特征有关，但具有高度的结构新奇和多样性。 通过多样性导向合成产生的文库具有骨架、取代和立体化学变化。 (2)高效和可靠的荧光标记和分离技术用于产生大多数建议的文库。 使用“快速合成系统”作为集成的合成平台显著地减少了反应和分离的时间。 其他成本控制技术，例如“一石二鸟”型氟标记/切割、共享公共构建块以及回收/重复使用氟标签和硅胶将用于生产库。 (3)图书馆设计/开发与图书馆制作的工作是平衡的。 中试规模库的设计和开发是建立在成功的内部化学基础上的。 更多的努力是针对图书馆生产，以产生提交的化合物，从而满足NIH的目标。 具体目标是：（1）马匹辛类天然产物库的合成;（2）靛地酮类天然产物库的合成;（3）菌核素类天然产物库的合成;（4）新颖多样的含氮多环库的合成;（5）含二酮哌嗪类天然产物库的合成;（6）多环醚类和生物碱类库的合成。 在为期三年的资助期内，将从6个项目中开发约30个库支架，每年生产和提交800- 1，000种化合物。 RFA关于文库制作和提交的一般指南，包括文库大小、质量控制、样品交付、数据管理和专利问题，将得到严格遵守。 在本RFA下生成的数据，包括库合成程序和化合物表征，以及合成技术和仪器等研究资源，将自愿与对筛选和/或研究本提案中产生的化合物感兴趣的未来合作者共享。